The Role of Preclinical CROs in the IND Enabling Process
A Preclinical CRO serves as an essential partner in the "bench-to-bedside" transition, specifically during the Investigational New Drug (IND) enabling phase. Before a candidate molecule can be tested in humans, it must undergo a rigorous battery of safety and efficacy evaluations. These assessments are designed to define the pharmacological profile of the drug, identify potential toxicities,...
0 Commentarios 0 Acciones 12 Views 0 Vista previa